The heart and the kidney fail together. Each makes the other worse, and treating one in isolation usually makes the other worse still.
That circularity is what cardiorenal syndrome names, and why it is one of the harder problems in medicine.
The bind
A patient in heart failure is overloaded with fluid. Diuretics remove it. The creatinine rises. Someone stops the diuretic.
The patient is now still overloaded, and worse off.
Here is the part that is frequently misunderstood: a rising creatinine during decongestion is not necessarily kidney injury. It often reflects hemoconcentration as excess fluid leaves — and patients whose creatinine rises while they decongest properly do better than patients whose creatinine stays flat because their diuretic was withheld.
The number moves in the wrong direction while the patient improves. Reacting to the number instead of the patient is the central error of this condition.
Venous congestion, not low output
The old model held that the kidney fails because the heart cannot push enough blood forward. That is part of it.
But congestion — elevated pressure in the veins draining the kidney — turns out to matter more. Blood cannot leave the kidney, so filtration falls. Central venous pressure correlates better with kidney dysfunction in heart failure than cardiac output does.
The implication is direct: getting the fluid off is usually what helps the kidney, not backing away from diuresis.
The five types
Acute heart failure injuring the kidney. Chronic heart failure damaging it over time. Acute kidney injury straining the heart. Chronic kidney disease driving cardiovascular disease. And a systemic illness — sepsis, diabetes, amyloidosis — damaging both.
The classification matters because the direction of causation determines what you treat first.
| Type | Primary problem | Effect on the other organ |
|---|---|---|
| Type 1 | Acute heart failure | Sudden kidney injury |
| Type 2 | Chronic heart failure | Progressive kidney disease |
| Type 3 | Acute kidney injury | Acute strain on the heart |
| Type 4 | Chronic kidney disease | Chronic damage to the heart |
| Type 5 | A systemic illness (e.g. sepsis) | Both organs at once |
What we do
Decongest properly. Loop diuretics at adequate doses, often intravenously, often higher than expected — diuretic resistance is common in this population and underdosing is the most frequent reason diuresis fails.
Sequential nephron blockade when a loop diuretic alone stalls: adding a thiazide, acetazolamide, or an SGLT2 inhibitor to block sodium reabsorption at a second site.
Ultrafiltration when the kidneys cannot respond at all.
Preserve the drugs that work. ACE inhibitors, ARBs, ARNIs, SGLT2 inhibitors, and mineralocorticoid antagonists all improve survival in heart failure and all protect kidneys. They also raise creatinine and potassium modestly, and they get stopped for that reason constantly.
A potassium binder usually makes stopping unnecessary. Keeping a patient on guideline-directed therapy by managing the numbers around it is among the most valuable things done here.
Assess volume accurately. Physical examination, weights, and where appropriate ultrasound or invasive measurement. Deciding whether a patient is wet or dry is the whole game, and getting it wrong sends treatment in exactly the wrong direction.
Who manages this
Both the cardiologist and the nephrologist, at the same time. Alternating between them — diuresing until the creatinine rises, stopping, waiting, restarting — is how these patients end up hospitalized repeatedly.